Home » Posts tagged with » biosimilars

Colorado bill ensures full access to meds

Patients with severe chronic disease are eager to gain access to a new class of medications known as “biosimilars,” which are less expensive imitations of “biologic” medications, yet have proven highly effective at treating a wide range of debilitating diseases including rheumatoid arthritis, multiple sclerosis, many types of cancer, psoriasis and lupus, among others. Right… Continue Reading Colorado bill ensures full access to meds